Biaxin
NDC 54868-3384
Product Information
Biaxin is a NDA-approved product labeled by Physicians Total Care, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 54868-3384 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 54868-3384?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CLARITHROMYCIN (UNII: H1250JIK0A)
- CLARITHROMYCIN (UNII: H1250JIK0A) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- CASTOR OIL (UNII: D5340Y2I9G)
- MALTODEXTRIN (UNII: 7CVR7L4A2D)
- POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
- POVIDONE (UNII: FZ989GH94E)
- SUCROSE (UNII: C151H8M554)
- XANTHAN GUM (UNII: TTV12P4NEE)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 197516 - clarithromycin 250 MG Oral Tablet
- RxCUI: 197517 - clarithromycin 500 MG Oral Tablet
- RxCUI: 205857 - clarithromycin 25 MG/ML Oral Suspension [Biaxin]
- RxCUI: 205857 - Biaxin 125 MG per 5 ML Granules for Oral Suspension
- RxCUI: 205857 - Biaxin 25 MG/ML Oral Suspension
* Please review the full disclaimer at the bottom of this page.